Open questions between immune checkpoint inhibitors and tuberculosis incidence

被引：0
|
作者：
Wen, Ying [1 ]
Kang, Jing [2 ]
机构：
[1] China Med Univ, Affiliated Hosp 1, Dept Infect Dis, 155 Nanjing North St, Shenyang 110001, Peoples R China
[2] China Med Univ, Hosp China Med Univ 1, Natl Clin Res Ctr Lab Med, State Key Lab Diag & Treatment Infect Dis,NHC Key, Shenyang, Peoples R China
来源：
JOURNAL OF THORACIC DISEASE | 2024年 / 16卷 / 08期
关键词：
D O I：
10.21037/jtd-24-890
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：5484 / 5486
页数：3
相关论文
共 50 条
  • [21] Immune checkpoint inhibitors
    Kroemer, Guido
    Zitvogel, Laurence
    JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 218 (03):
  • [22] Should immune checkpoint inhibitors be contraindicated in lung cancer patients with latent tuberculosis?
    Haddad, Fady G. H.
    Kattan, Clarisse
    Kattan, Joseph
    IMMUNOTHERAPY, 2020, 12 (11) : 759 - 762
  • [23] Incidence of immune-related adverse events in US veterans treated with immune checkpoint inhibitors
    Krall, Courtney
    Tague, Marshall
    Lund, Brian C.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024, 30 (08) : 1372 - 1377
  • [24] Overview of the molecular interactions between radiotherapy and the immune system and immune checkpoint inhibitors
    Melcher, A.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S177 - S177
  • [25] An Increased Understanding of the Association Between Atherosclerosis and Immune Checkpoint Inhibitors
    Judah M. Ellison
    Anju Nohria
    Current Cardiology Reports, 2023, 25 : 879 - 887
  • [26] Incidence of adrenal insufficiency in patients with solid malignancies treated with immune checkpoint inhibitors
    Archambault, Alexi
    Wang, Juan
    Byrne, Shauna
    Gullo, Giuseppe
    Hampp, Christian
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 233 - 233
  • [27] INCIDENCE AND OUTCOMES OF RENAL ADVERSE EVENTS FOLLOWING TREATMENT WITH IMMUNE CHECKPOINT INHIBITORS
    Maccan, Jessica
    Kolovos, Peter
    Stevanovic, Amanda
    Bose, Bhadran
    Komala, Muralikrishna Gangadharan
    NEPHROLOGY, 2022, 27 : 29 - 30
  • [28] An Increased Understanding of the Association Between Atherosclerosis and Immune Checkpoint Inhibitors
    Ellison, Judah M.
    Nohria, Anju
    CURRENT CARDIOLOGY REPORTS, 2023, 25 (08) : 879 - 887
  • [29] Risk Stratification and Real World Incidence of Cardiac Toxicity With Immune Checkpoint Inhibitors
    Hu, Jian
    Shnoda, Mina
    Pappan, Nikos
    Kyvernitakis, Andreas
    Poornima, Indu G.
    CIRCULATION, 2020, 142
  • [30] The spectrum, incidence, kinetics and management of endocrinopathies with immune checkpoint inhibitors for metastatic melanoma
    Scott, Emma S.
    Long, Georgina V.
    Guminski, Alexander
    Clifton-Bligh, Roderick J.
    Menzies, Alexander M.
    Tsang, Venessa H.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2018, 178 (02) : 173 - 180
12345